April - June 2020 Quarter will truly show the new lean Admedus, as this Q and next will still have charges related to the selling out of the Patch Business.
Although I agree with Eire2011 that 4C releases will be a none event from now on.
Admedus 3D valve the way nature intended to be. One piece. Bring on the human trials.
Why Admedus’ shift to aortic valve replacement is good news for patients under 65, page-33
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |